Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 3 |
GO:0043226 | organelle | 2 | 3 |
GO:0043227 | membrane-bounded organelle | 3 | 3 |
GO:0043229 | intracellular organelle | 3 | 3 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
Related structures:
AlphaFold database: E9AM14
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 11 |
GO:0006259 | DNA metabolic process | 4 | 11 |
GO:0006281 | DNA repair | 5 | 11 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
GO:0006950 | response to stress | 2 | 11 |
GO:0006974 | DNA damage response | 4 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0033554 | cellular response to stress | 3 | 11 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 11 |
GO:0046483 | heterocycle metabolic process | 3 | 11 |
GO:0050896 | response to stimulus | 1 | 11 |
GO:0051716 | cellular response to stimulus | 2 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:0090304 | nucleic acid metabolic process | 4 | 11 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 11 |
GO:0003677 | DNA binding | 4 | 11 |
GO:0003824 | catalytic activity | 1 | 11 |
GO:0004518 | nuclease activity | 4 | 11 |
GO:0004527 | exonuclease activity | 5 | 11 |
GO:0004529 | DNA exonuclease activity | 5 | 11 |
GO:0004536 | DNA nuclease activity | 4 | 11 |
GO:0005488 | binding | 1 | 11 |
GO:0008409 | 5'-3' exonuclease activity | 6 | 11 |
GO:0016787 | hydrolase activity | 2 | 11 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 11 |
GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 6 | 11 |
GO:0016895 | DNA exonuclease activity, producing 5'-phosphomonoesters | 6 | 11 |
GO:0033699 | DNA 5'-adenosine monophosphate hydrolase activity | 8 | 11 |
GO:0035312 | 5'-3' DNA exonuclease activity | 7 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:0140097 | catalytic activity, acting on DNA | 3 | 11 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
GO:0043167 | ion binding | 2 | 3 |
GO:0043169 | cation binding | 3 | 3 |
GO:0046872 | metal ion binding | 4 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 178 | 182 | PF00656 | 0.416 |
CLV_NRD_NRD_1 | 13 | 15 | PF00675 | 0.593 |
CLV_NRD_NRD_1 | 156 | 158 | PF00675 | 0.305 |
CLV_NRD_NRD_1 | 38 | 40 | PF00675 | 0.279 |
CLV_PCSK_KEX2_1 | 13 | 15 | PF00082 | 0.640 |
CLV_PCSK_KEX2_1 | 156 | 158 | PF00082 | 0.305 |
CLV_PCSK_KEX2_1 | 36 | 38 | PF00082 | 0.263 |
CLV_PCSK_PC1ET2_1 | 36 | 38 | PF00082 | 0.331 |
DEG_APCC_DBOX_1 | 24 | 32 | PF00400 | 0.389 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.647 |
DOC_CDC14_PxL_1 | 162 | 170 | PF14671 | 0.401 |
DOC_CDC14_PxL_1 | 68 | 76 | PF14671 | 0.408 |
DOC_CYCLIN_yCln2_LP_2 | 109 | 115 | PF00134 | 0.426 |
DOC_MAPK_gen_1 | 25 | 34 | PF00069 | 0.464 |
DOC_PP2B_LxvP_1 | 109 | 112 | PF13499 | 0.401 |
DOC_USP7_MATH_1 | 16 | 20 | PF00917 | 0.484 |
DOC_USP7_MATH_1 | 164 | 168 | PF00917 | 0.443 |
DOC_USP7_MATH_1 | 246 | 250 | PF00917 | 0.400 |
DOC_USP7_MATH_1 | 38 | 42 | PF00917 | 0.517 |
DOC_USP7_MATH_1 | 51 | 55 | PF00917 | 0.567 |
DOC_USP7_MATH_1 | 82 | 86 | PF00917 | 0.293 |
DOC_USP7_UBL2_3 | 258 | 262 | PF12436 | 0.470 |
DOC_USP7_UBL2_3 | 36 | 40 | PF12436 | 0.483 |
DOC_WW_Pin1_4 | 1 | 6 | PF00397 | 0.532 |
DOC_WW_Pin1_4 | 179 | 184 | PF00397 | 0.427 |
DOC_WW_Pin1_4 | 46 | 51 | PF00397 | 0.592 |
DOC_WW_Pin1_4 | 72 | 77 | PF00397 | 0.494 |
LIG_14-3-3_CanoR_1 | 13 | 20 | PF00244 | 0.505 |
LIG_14-3-3_CanoR_1 | 214 | 218 | PF00244 | 0.306 |
LIG_14-3-3_CanoR_1 | 37 | 45 | PF00244 | 0.324 |
LIG_Actin_WH2_2 | 130 | 148 | PF00022 | 0.505 |
LIG_BIR_III_2 | 99 | 103 | PF00653 | 0.401 |
LIG_CtBP_PxDLS_1 | 112 | 116 | PF00389 | 0.426 |
LIG_DLG_GKlike_1 | 116 | 123 | PF00625 | 0.505 |
LIG_FHA_1 | 47 | 53 | PF00498 | 0.678 |
LIG_FHA_2 | 122 | 128 | PF00498 | 0.474 |
LIG_FHA_2 | 176 | 182 | PF00498 | 0.416 |
LIG_LIR_Gen_1 | 193 | 200 | PF02991 | 0.382 |
LIG_LIR_Nem_3 | 139 | 144 | PF02991 | 0.426 |
LIG_LIR_Nem_3 | 193 | 197 | PF02991 | 0.361 |
LIG_LIR_Nem_3 | 66 | 71 | PF02991 | 0.314 |
LIG_LYPXL_yS_3 | 71 | 74 | PF13949 | 0.392 |
LIG_MYND_1 | 72 | 76 | PF01753 | 0.488 |
LIG_Pex14_2 | 158 | 162 | PF04695 | 0.412 |
LIG_Pex14_2 | 194 | 198 | PF04695 | 0.237 |
LIG_PTB_Apo_2 | 95 | 102 | PF02174 | 0.401 |
LIG_SH2_STAT5 | 141 | 144 | PF00017 | 0.398 |
LIG_SH3_3 | 163 | 169 | PF00018 | 0.401 |
LIG_SH3_3 | 239 | 245 | PF00018 | 0.350 |
LIG_SH3_3 | 47 | 53 | PF00018 | 0.566 |
LIG_WRC_WIRS_1 | 191 | 196 | PF05994 | 0.257 |
LIG_WRPW_2 | 68 | 71 | PF00400 | 0.425 |
MOD_CDK_SPxxK_3 | 179 | 186 | PF00069 | 0.427 |
MOD_CK1_1 | 19 | 25 | PF00069 | 0.441 |
MOD_CK1_1 | 193 | 199 | PF00069 | 0.252 |
MOD_CK1_1 | 41 | 47 | PF00069 | 0.457 |
MOD_CK1_1 | 54 | 60 | PF00069 | 0.559 |
MOD_CK2_1 | 54 | 60 | PF00069 | 0.647 |
MOD_CK2_1 | 72 | 78 | PF00069 | 0.495 |
MOD_GlcNHglycan | 40 | 43 | PF01048 | 0.460 |
MOD_GSK3_1 | 12 | 19 | PF00069 | 0.559 |
MOD_GSK3_1 | 175 | 182 | PF00069 | 0.549 |
MOD_GSK3_1 | 246 | 253 | PF00069 | 0.267 |
MOD_GSK3_1 | 41 | 48 | PF00069 | 0.454 |
MOD_GSK3_1 | 51 | 58 | PF00069 | 0.558 |
MOD_GSK3_1 | 72 | 79 | PF00069 | 0.347 |
MOD_PKA_2 | 12 | 18 | PF00069 | 0.577 |
MOD_PKA_2 | 213 | 219 | PF00069 | 0.306 |
MOD_PKA_2 | 38 | 44 | PF00069 | 0.523 |
MOD_Plk_4 | 101 | 107 | PF00069 | 0.401 |
MOD_Plk_4 | 193 | 199 | PF00069 | 0.349 |
MOD_Plk_4 | 83 | 89 | PF00069 | 0.355 |
MOD_ProDKin_1 | 1 | 7 | PF00069 | 0.533 |
MOD_ProDKin_1 | 179 | 185 | PF00069 | 0.427 |
MOD_ProDKin_1 | 46 | 52 | PF00069 | 0.591 |
MOD_ProDKin_1 | 72 | 78 | PF00069 | 0.491 |
MOD_SUMO_rev_2 | 228 | 235 | PF00179 | 0.257 |
MOD_SUMO_rev_2 | 75 | 82 | PF00179 | 0.438 |
TRG_DiLeu_BaLyEn_6 | 126 | 131 | PF01217 | 0.444 |
TRG_DiLeu_BaLyEn_6 | 69 | 74 | PF01217 | 0.488 |
TRG_ENDOCYTIC_2 | 191 | 194 | PF00928 | 0.250 |
TRG_ENDOCYTIC_2 | 71 | 74 | PF00928 | 0.402 |
TRG_ER_diArg_1 | 12 | 14 | PF00400 | 0.630 |
TRG_ER_diArg_1 | 156 | 158 | PF00400 | 0.505 |
TRG_NLS_MonoExtC_3 | 35 | 40 | PF00514 | 0.228 |
TRG_Pf-PMV_PEXEL_1 | 204 | 208 | PF00026 | 0.306 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IB39 | Leptomonas seymouri | 71% | 100% |
A0A0S4IR98 | Bodo saltans | 40% | 100% |
A0A0S4JC46 | Bodo saltans | 29% | 84% |
A0A0S4JGA0 | Bodo saltans | 39% | 100% |
A0A1X0NZZ4 | Trypanosomatidae | 51% | 100% |
A0A3S7X266 | Leishmania donovani | 91% | 100% |
A4HH71 | Leishmania braziliensis | 83% | 100% |
A4I4B7 | Leishmania infantum | 92% | 100% |
C9ZL51 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
O74859 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 30% | 100% |
P61797 | Canis lupus familiaris | 33% | 77% |
P61798 | Gallus gallus | 35% | 84% |
P61801 | Xenopus tropicalis | 34% | 76% |
Q08702 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 27% | 100% |
Q7Z2E3 | Homo sapiens | 34% | 74% |
Q8K4H4 | Rattus norvegicus | 34% | 80% |
V5BUM6 | Trypanosoma cruzi | 51% | 100% |